Clinical trial
Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy
NCT01094769 is registered in ClinicalTrials.gov with Baker Heart and Diabetes Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Sympathetic Nervous System Inhibition for the Treatment of Diabetic Nephropathy
- Lead sponsor
- Baker Heart and Diabetes Institute
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2011
- Completion date
- April 30, 2020
- Enrollment
- 48 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.